MedPath

Levetroy

Brand Name: Levetroy

Generic Name: Levetiracetam

Active
Registration Number

DR-XY49106

Dosage Form

Concentrate Solution for Injection (IV Infusion)

Issuance Date

May 21, 2025

Expiry Date

May 21, 2030

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength100 mg/mL
Packaging5 mL Clear Glass Vial (Ph.Eur. Type I) with 20 mm Bromobutyl Rubber Stopper and 20 mm White Flip off Seal (Box of 1's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Antiepileptic
A
Application
Variation (Turned Initial)
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

LevetiracetamActive
Monograph: Levetiracetam

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform